On June 9, ON Semiconductor Corp (Nasdaq:ONNN), driving energy efficient innovations, signed a definitive agreement to acquire Aptina Imaging, a leading provider of high-performance CMOS image sensors for automotive and industrial markets, which are the key areas of strategic focus for ON Semiconductor. Other markets addressed by Aptina’s products include cameras, mobile devices, and computing and gaming platforms. ON Semiconductor Corp (NASDAQ:ONNN) net profit margin is 6.60% and weekly performance is 2.84%. On last trading day company shares ended up $9.06. Analysts mean target price for the company is $10.98. ON Semiconductor Corp (NASDAQ:ONNN) distance from 50-day simple moving average (SMA50) is -0.73%.
Shares of Pfizer Inc (NYSE:PFE) have received an average rating of “Buy” from the eighteen brokerages that are presently covering the company,AnalystRatingsNetwork.com reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $32.83. Pfizer Inc. (NYSE:PFE) shares advanced 0.51% in last trading session and ended the day on $29.50. Gross Margin is 81.90% and its return on assets is 23.50%. Pfizer Inc. (NYSE:PFE) quarterly performance is -8.19%.
General Electric Company (NYSE:GE)’s advanced water treatment technology will help purify water at IRPC Public Company Limited’s new combined heat and power (CHP) plant in Rayong, Thailand. GE’s ZeeWeed* 1500 ultrafiltration membranes, reverse osmosis(RO) and electrodeionization (EDI) technologies will be used to make high-quality demineralized water for boiler feed water and to reduce the use of chemicals. General Electric Company (NYSE:GE) shares moved down -0.11% in last trading session and was closed at $27.41, while trading in range of $27.24 – $27.46. General Electric Company (NYSE:GE) year to date (YTD) performance is -1.37%.
A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE:BSX) Vercise™ Deep Brain Stimulation (DBS) System for the treatment of Parkinson’s disease (PD). The CUSTOM-DBS clinical study demonstrated that shorter stimulation pulses may offer a clinical advantage over DBS therapy using conventional pulses. The Vercise DBS System is the only commercially available platform with the capability to generate stimulation pulses at the shorter pulse width settings. Boston Scientific Corporation (NYSE:BSX) ended the last trading day at $12.84. Company weekly volatility is calculated as 2.11% and price to cash ratio as 88.92. Boston Scientific Corporation (NYSE:BSX) showed a negative weekly performance of -1.00%.
RAINBOW INTERNATIONAL CORP (OTCMKTS:RNBI) On last trading day company shares ended up $0.248 .